| Ms Mary Ellen Ernst, CRNA | |
|
2 Progress Point Pkwy, Dept Anesthesiology, O Fallon, MO 63368-2205 | |
| (800) 862-9980 | |
| (314) 362-1185 |
| Full Name | Ms Mary Ellen Ernst |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 2 Progress Point Pkwy, O Fallon, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477864213 | NPI | - | NPPES |
| 914200001 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 2010020077 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western Anesthesiology Associates Inc | 6204720667 | 175 |
News Archive
Pancreas surgery specialist Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, and Co-Director of the Pancreatic, Biliary Tract and Related Cancer Center at Thomas Jefferson University Hospital, recently performed his 1,000th Whipple procedure (pancreaticoduodenectomy). Only one other surgeon in the United States has reached this milestone for this procedure. That surgeon is John Cameron, M.D., Professor, Department of Surgery at The Johns Hopkins Hospital.
HPV DNA testing for precancers and cervical cancers is over 50 per cent more sensitive than cytology testing for the same conditions a community-based study in Mexico has revealed. Results of the largest HPV DNA primary screening study ever to be performed in a Latin American country point to the readiness of HPV DNA testing for large-scale implementation in Mexico and are published online today (8 July 2010) in Cancer, Causes and Controls.
Ingrown hair, also known as "razor bumps," are a common skin condition, particularly in people whose hair has the tendency to curl back or grow sideways in a hair follicle.
Onconova Therapeutics, Inc., and SymBio Pharmaceuticals Limited announced today that they will collaborate to develop and commercialize rigosertib in Japan and Korea. Onconova is conducting late-stage clinical trials with rigosertib (ON 01910.Na) in the U.S., Europe and India for the treatment of Myelodysplastic Syndromes (MDS) and solid tumors.
This "carefully crafted" approach fell short of the needed support,but its backers vow to return next year with a new proposal. News outlets also provide updates on expansion efforts in Nevada, Virginia and Ohio.
› Verified 8 days ago
| Entity Name | Washington University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528005642 PECOS PAC ID: 9830008770 Enrollment ID: O20031118001093 |
News Archive
Pancreas surgery specialist Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, and Co-Director of the Pancreatic, Biliary Tract and Related Cancer Center at Thomas Jefferson University Hospital, recently performed his 1,000th Whipple procedure (pancreaticoduodenectomy). Only one other surgeon in the United States has reached this milestone for this procedure. That surgeon is John Cameron, M.D., Professor, Department of Surgery at The Johns Hopkins Hospital.
HPV DNA testing for precancers and cervical cancers is over 50 per cent more sensitive than cytology testing for the same conditions a community-based study in Mexico has revealed. Results of the largest HPV DNA primary screening study ever to be performed in a Latin American country point to the readiness of HPV DNA testing for large-scale implementation in Mexico and are published online today (8 July 2010) in Cancer, Causes and Controls.
Ingrown hair, also known as "razor bumps," are a common skin condition, particularly in people whose hair has the tendency to curl back or grow sideways in a hair follicle.
Onconova Therapeutics, Inc., and SymBio Pharmaceuticals Limited announced today that they will collaborate to develop and commercialize rigosertib in Japan and Korea. Onconova is conducting late-stage clinical trials with rigosertib (ON 01910.Na) in the U.S., Europe and India for the treatment of Myelodysplastic Syndromes (MDS) and solid tumors.
This "carefully crafted" approach fell short of the needed support,but its backers vow to return next year with a new proposal. News outlets also provide updates on expansion efforts in Nevada, Virginia and Ohio.
› Verified 8 days ago
| Entity Name | Western Anesthesiology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275646754 PECOS PAC ID: 6204720667 Enrollment ID: O20040209000602 |
News Archive
Pancreas surgery specialist Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, and Co-Director of the Pancreatic, Biliary Tract and Related Cancer Center at Thomas Jefferson University Hospital, recently performed his 1,000th Whipple procedure (pancreaticoduodenectomy). Only one other surgeon in the United States has reached this milestone for this procedure. That surgeon is John Cameron, M.D., Professor, Department of Surgery at The Johns Hopkins Hospital.
HPV DNA testing for precancers and cervical cancers is over 50 per cent more sensitive than cytology testing for the same conditions a community-based study in Mexico has revealed. Results of the largest HPV DNA primary screening study ever to be performed in a Latin American country point to the readiness of HPV DNA testing for large-scale implementation in Mexico and are published online today (8 July 2010) in Cancer, Causes and Controls.
Ingrown hair, also known as "razor bumps," are a common skin condition, particularly in people whose hair has the tendency to curl back or grow sideways in a hair follicle.
Onconova Therapeutics, Inc., and SymBio Pharmaceuticals Limited announced today that they will collaborate to develop and commercialize rigosertib in Japan and Korea. Onconova is conducting late-stage clinical trials with rigosertib (ON 01910.Na) in the U.S., Europe and India for the treatment of Myelodysplastic Syndromes (MDS) and solid tumors.
This "carefully crafted" approach fell short of the needed support,but its backers vow to return next year with a new proposal. News outlets also provide updates on expansion efforts in Nevada, Virginia and Ohio.
› Verified 8 days ago
| Entity Name | Western Anesthesiology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275646754 PECOS PAC ID: 6204720667 Enrollment ID: O20040226000438 |
News Archive
Pancreas surgery specialist Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, and Co-Director of the Pancreatic, Biliary Tract and Related Cancer Center at Thomas Jefferson University Hospital, recently performed his 1,000th Whipple procedure (pancreaticoduodenectomy). Only one other surgeon in the United States has reached this milestone for this procedure. That surgeon is John Cameron, M.D., Professor, Department of Surgery at The Johns Hopkins Hospital.
HPV DNA testing for precancers and cervical cancers is over 50 per cent more sensitive than cytology testing for the same conditions a community-based study in Mexico has revealed. Results of the largest HPV DNA primary screening study ever to be performed in a Latin American country point to the readiness of HPV DNA testing for large-scale implementation in Mexico and are published online today (8 July 2010) in Cancer, Causes and Controls.
Ingrown hair, also known as "razor bumps," are a common skin condition, particularly in people whose hair has the tendency to curl back or grow sideways in a hair follicle.
Onconova Therapeutics, Inc., and SymBio Pharmaceuticals Limited announced today that they will collaborate to develop and commercialize rigosertib in Japan and Korea. Onconova is conducting late-stage clinical trials with rigosertib (ON 01910.Na) in the U.S., Europe and India for the treatment of Myelodysplastic Syndromes (MDS) and solid tumors.
This "carefully crafted" approach fell short of the needed support,but its backers vow to return next year with a new proposal. News outlets also provide updates on expansion efforts in Nevada, Virginia and Ohio.
› Verified 8 days ago
| Entity Name | Midwest Anesthesia Providers Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295189082 PECOS PAC ID: 9830480581 Enrollment ID: O20160712001846 |
News Archive
Pancreas surgery specialist Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, and Co-Director of the Pancreatic, Biliary Tract and Related Cancer Center at Thomas Jefferson University Hospital, recently performed his 1,000th Whipple procedure (pancreaticoduodenectomy). Only one other surgeon in the United States has reached this milestone for this procedure. That surgeon is John Cameron, M.D., Professor, Department of Surgery at The Johns Hopkins Hospital.
HPV DNA testing for precancers and cervical cancers is over 50 per cent more sensitive than cytology testing for the same conditions a community-based study in Mexico has revealed. Results of the largest HPV DNA primary screening study ever to be performed in a Latin American country point to the readiness of HPV DNA testing for large-scale implementation in Mexico and are published online today (8 July 2010) in Cancer, Causes and Controls.
Ingrown hair, also known as "razor bumps," are a common skin condition, particularly in people whose hair has the tendency to curl back or grow sideways in a hair follicle.
Onconova Therapeutics, Inc., and SymBio Pharmaceuticals Limited announced today that they will collaborate to develop and commercialize rigosertib in Japan and Korea. Onconova is conducting late-stage clinical trials with rigosertib (ON 01910.Na) in the U.S., Europe and India for the treatment of Myelodysplastic Syndromes (MDS) and solid tumors.
This "carefully crafted" approach fell short of the needed support,but its backers vow to return next year with a new proposal. News outlets also provide updates on expansion efforts in Nevada, Virginia and Ohio.
› Verified 8 days ago
| Entity Name | Orthomed Staffing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225514276 PECOS PAC ID: 9638429178 Enrollment ID: O20220505000502 |
News Archive
Pancreas surgery specialist Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, and Co-Director of the Pancreatic, Biliary Tract and Related Cancer Center at Thomas Jefferson University Hospital, recently performed his 1,000th Whipple procedure (pancreaticoduodenectomy). Only one other surgeon in the United States has reached this milestone for this procedure. That surgeon is John Cameron, M.D., Professor, Department of Surgery at The Johns Hopkins Hospital.
HPV DNA testing for precancers and cervical cancers is over 50 per cent more sensitive than cytology testing for the same conditions a community-based study in Mexico has revealed. Results of the largest HPV DNA primary screening study ever to be performed in a Latin American country point to the readiness of HPV DNA testing for large-scale implementation in Mexico and are published online today (8 July 2010) in Cancer, Causes and Controls.
Ingrown hair, also known as "razor bumps," are a common skin condition, particularly in people whose hair has the tendency to curl back or grow sideways in a hair follicle.
Onconova Therapeutics, Inc., and SymBio Pharmaceuticals Limited announced today that they will collaborate to develop and commercialize rigosertib in Japan and Korea. Onconova is conducting late-stage clinical trials with rigosertib (ON 01910.Na) in the U.S., Europe and India for the treatment of Myelodysplastic Syndromes (MDS) and solid tumors.
This "carefully crafted" approach fell short of the needed support,but its backers vow to return next year with a new proposal. News outlets also provide updates on expansion efforts in Nevada, Virginia and Ohio.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Mary Ellen Ernst, CRNA Po Box 60352, Saint Louis, MO 63160-0352 Ph: (800) 862-9980 | Ms Mary Ellen Ernst, CRNA 2 Progress Point Pkwy, Dept Anesthesiology, O Fallon, MO 63368-2205 Ph: (800) 862-9980 |
News Archive
Pancreas surgery specialist Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, and Co-Director of the Pancreatic, Biliary Tract and Related Cancer Center at Thomas Jefferson University Hospital, recently performed his 1,000th Whipple procedure (pancreaticoduodenectomy). Only one other surgeon in the United States has reached this milestone for this procedure. That surgeon is John Cameron, M.D., Professor, Department of Surgery at The Johns Hopkins Hospital.
HPV DNA testing for precancers and cervical cancers is over 50 per cent more sensitive than cytology testing for the same conditions a community-based study in Mexico has revealed. Results of the largest HPV DNA primary screening study ever to be performed in a Latin American country point to the readiness of HPV DNA testing for large-scale implementation in Mexico and are published online today (8 July 2010) in Cancer, Causes and Controls.
Ingrown hair, also known as "razor bumps," are a common skin condition, particularly in people whose hair has the tendency to curl back or grow sideways in a hair follicle.
Onconova Therapeutics, Inc., and SymBio Pharmaceuticals Limited announced today that they will collaborate to develop and commercialize rigosertib in Japan and Korea. Onconova is conducting late-stage clinical trials with rigosertib (ON 01910.Na) in the U.S., Europe and India for the treatment of Myelodysplastic Syndromes (MDS) and solid tumors.
This "carefully crafted" approach fell short of the needed support,but its backers vow to return next year with a new proposal. News outlets also provide updates on expansion efforts in Nevada, Virginia and Ohio.
› Verified 8 days ago
Ms. Kris L Gallina, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2 Progress Point Ct, O Fallon, MO 63368 Phone: 636-344-1065 Fax: 636-344-1064 | |
Mr. Kyle Alan Wogtech, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2 Progress Point Pkwy, Dept Anesthesiology, O Fallon, MO 63368 Phone: 800-862-9980 Fax: 314-362-1185 | |
Ms. Rose Elizabeth Sullivan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2 Progress Point Pkwy, Dept Anesthesiology, O Fallon, MO 63368 Phone: 800-862-9980 Fax: 314-362-1185 | |
Ms. Christine Meyer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2 Progress Point Ct, O Fallon, MO 63368 Phone: 636-344-1170 Fax: 636-344-1138 | |
Ms. Andrea N Atkins, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2 Progress Point Ct, O Fallon, MO 63368 Phone: 636-344-1065 Fax: 636-344-6064 | |
Mrs. Abigail Clare Hughes-strange, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2 Progress Point Pkwy, Dept Anesthesiology, O Fallon, MO 63368 Phone: 800-862-9980 Fax: 314-362-1185 | |
William Moran, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 910 Daffodil Ridge Dr, O Fallon, MO 63366 Phone: 314-780-2257 |